Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
NCT05737953 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-02-11
Summary
The goal of this observational study is to test in patients with cystic tumor of pancreas. The main questions it aims to answer are:
Screening of molecular diagnostic markers for pancreatic cystic tumors by cfDNA methylation sequencing of pancreatic cystic fluid and proteomic assays to distinguish benign from malignant and mucinous/non-mucinous, correlate with pathological features, and find molecular features associated with the degree of malignancy.
Participants will Provide post-operative cyst fluid specimens.
Conditions
- Pancreatic Neoplasms
- DNA Methylation
- Proteome
Interventions
- DIAGNOSTIC_TEST
-
cfDNA methylation sequencing and proteome analysis
Sequencing of cfDNA methylation and proteomic analysis of two sets of capsular fluid samples
Sponsors & Collaborators
-
Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University
collaborator UNKNOWN -
Zhejiang University
collaborator OTHER -
The First Affiliated Hospital of Nanchang University
collaborator OTHER -
West China Hospital
collaborator OTHER -
LanZhou University
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
collaborator OTHER -
Peking University Cancer Hospital & Institute
collaborator OTHER -
First Hospital of China Medical University
collaborator OTHER -
First Affiliated Hospital of Guangxi Medical University
collaborator OTHER -
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
collaborator OTHER -
The Second Affiliated Hospital of Baotou Medical College
collaborator OTHER -
Shandong Province Third hospital
collaborator OTHER -
Zhaoshen Li
lead OTHER
Principal Investigators
-
Shiyu Li · Changhai Hospital
-
Chengye Pan · Changhai Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- China
Study Locations
More Related Trials
-
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
NCT03855800 ·Status: RECRUITING ·Phase: NA
-
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
NCT04572594 ·Status: UNKNOWN
-
Expression and Clinical Significance of IGHD in Pancreatic Cancer
NCT05327400 ·Status: UNKNOWN
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
NCT01807325 ·Status: COMPLETED
-
Upper GI Serial Tumour Biopsies
NCT05233007 ·Status: SUSPENDED
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Cancer Detection in Pancreatic Cysts
NCT00222898 ·Status: COMPLETED
-
Biomarker Analysis of Gastrointestinal Cancer
NCT01484444 ·Status: UNKNOWN
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer:MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
NCT06653062 ·Status: RECRUITING
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN
-
DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer
NCT02079363 ·Status: UNKNOWN
-
Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas
NCT05783973 ·Status: UNKNOWN
-
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941 ·Status: NOT_YET_RECRUITING
-
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
NCT05027828 ·Status: RECRUITING
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962 ·Status: RECRUITING
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases
NCT05896956 ·Status: NOT_YET_RECRUITING
-
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NCT05853198 ·Status: RECRUITING ·Phase: NA
-
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
NCT05379907 ·Status: WITHDRAWN